The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid
RM Cabrera, JP Souder, JW Steele, L Yeo, G Tukeman… - Aids, 2019 - journals.lww.com
Objective: Maternal folate (vitamin B9) status is the largest known modifier of neural tube
defect risk, so we evaluated folate-related mechanisms of action for dolutegravir (DTG) …
defect risk, so we evaluated folate-related mechanisms of action for dolutegravir (DTG) …
Structural determinants for protein unfolding and translocation by the Hsp104 protein disaggregase
The ring-forming Hsp104 ATPase cooperates with Hsp70 and Hsp40 molecular chaperones
to rescue stress-damaged proteins from both amorphous and amyloid-forming aggregates. …
to rescue stress-damaged proteins from both amorphous and amyloid-forming aggregates. …
Ku DNA End-Binding Activity Promotes Repair Fidelity and Influences End-Processing During Nonhomologous End-Joining in Saccharomyces cerevisiae
…, A Ribes-Zamora, EJ Polleys, CL Williams, L Yeo… - Genetics, 2018 - academic.oup.com
The Ku heterodimer acts centrally in nonhomologous end-joining (NHEJ) of DNA double-strand
breaks (DSB). Saccharomyces cerevisiae Ku, like mammalian Ku, binds and recruits …
breaks (DSB). Saccharomyces cerevisiae Ku, like mammalian Ku, binds and recruits …
S17 Therapeutic Drug Monitoring of the Biosimilar (AMJEVITA™, Adalimumab-atto) Using Labcorp Adalimumab Assay for Drug Level and Anti-Drug Antibodies
KY Chun, M Bastidas, L Yeo, S Magpantay… - Official journal of the …, 2023 - journals.lww.com
Background: Therapeutic drug monitoring (TDM) of adalimumab (ADL) concentration and
anti-adalimumab antibody titers informs physician clinical decision-making in the management …
anti-adalimumab antibody titers informs physician clinical decision-making in the management …
The Antagonism of Folate Receptor by the Integrase Inhibitor Dolutegravir: Developmental Toxicity Reduction by Supplemental Folic Acid
RM Cabrera, JP Souder, JW Steele, L Yeo, G Tukeman… - bioRxiv, 2019 - biorxiv.org
Human immunodeficiency virus (HIV) integrase inhibitors are increasingly being used for
antiretroviral therapy (ART), and dolutegravir (DTG/Tivicay) has emerged as a leading core …
antiretroviral therapy (ART), and dolutegravir (DTG/Tivicay) has emerged as a leading core …
[HTML][HTML] Yeast casein kinase 2 governs morphology, biofilm formation, cell wall integrity, and host cell damage of Candida albicans
SI Jung, N Rodriguez, J Irrizary, K Liboro, T Bogarin… - PLoS …, 2017 - journals.plos.org
… We thank Jesses Garcia, and Peng-Yi Zhu and Lythou Yeo and Norma Solis for technical
assistance in fluorescent microscopy, and biofilm assay, and host cell damage assay, …
assistance in fluorescent microscopy, and biofilm assay, and host cell damage assay, …
S14 Impact of Body Mass Index as Predictor for Surgical Interventions in Crohn's Disease Strictures
Background: Half of patients with Crohn’s disease (CD) develop strictures within 20 years
from disease diagnosis. Many of these patients require either endoscopic and/or surgical …
from disease diagnosis. Many of these patients require either endoscopic and/or surgical …
S15 Recombinant Zoster Vaccine (RZV) is Effective in Reducing Herpes Zoster Infection in Patients With Inflammatory Bowel Disease: A US Propensity Matched …
Background: Recombinant zoster vaccine (RZV) has been shown to reduce the short-term
risk of herpes zoster (HZ) in patients with inflammatory bowel disease (IBD). However, there is …
risk of herpes zoster (HZ) in patients with inflammatory bowel disease (IBD). However, there is …
" Bootstrap Theatre": A Prompt Book for The Fantasticks
JA Ball - 1983 - thekeep.eiu.edu
This paper is the description of a creative fine arts project involving the direction and design
of a full-length musical theatre production within a very low working budget. The purpose of …
of a full-length musical theatre production within a very low working budget. The purpose of …
S16 Subcutaneous Versus Intravenous Infliximab Therapy: Toward Higher Drug Concentrations
AI Ferreira, C Arieira, S Xavier… - Official journal of the …, 2023 - journals.lww.com
Background: Subcutaneous infliximab (SC-IFX) has been associated with a more favorable
pharmacokinetic profile than intravenous infliximab (IV-IFX) in patients with inflammatory …
pharmacokinetic profile than intravenous infliximab (IV-IFX) in patients with inflammatory …